AABB eCasts

Managing Platelet Refractoriness: Strategies for Diagnosis and Treatment (25EL-557)

When
Where
Virtual

Event details

A subset of patients with hematologic malignancies develop immune-based refractoriness to platelet transfusions. Diagnosing and dealing with platelet refractoriness is critical for a patient’s survival. This program will explore the basis of refractoriness, standard strategies used, and alternative strategies when nothing else works.

Presented by

Laura Staller, MHA, MLS(ASCP)CM
Director/Moderator
Manager, Cryopreservation Service, NMDP
Minneapolis, MN

Claudia S. Cohn, MD, PhD
Speaker
Medical Director, Blood Bank Lab for University of Minnesota, Minneapolis, MN
Chief Medical Officer, AABB, Bethesda, MD

Learning objectives

After participating in this educational activity, participants should be able to:

  • Describe the basis for platelet refractoriness.
  • Discuss standard strategies to overcome platelet refractoriness.
  • Identify alternative strategies when HLA matching does not work.

Registration

Registration includes access to both the live and on-demand version of this eCast. Registration for the live eCast will close 1 hour prior to the eCast start time. If you register after this time, you will receive access to the on-demand eCast when it is available.

For additional information and to register as a single viewer or group, visit the AABB event webpage. Please note: Registration fees are required for AABB events.